GL1X · GenesisL1 explorer

MolNFT v1 · #162359 · protein

Crystal structure of transthyretin mutant A25T in complex with CHF5074, a flurbiprofen analogue

6R6I: “Crystal structure of transthyretin mutant A25T in complex with CHF5074, a flurbiprofen analogue”. X-ray diffraction, 2 ligands (H50, PO4), 2 pockets (best druggability 0.34). MolNFT v1 #162359 on GenesisL1: 3D structure, binding…

PDB
6R6I
Type
protein
Length
231 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Transthyretin
UniProt
P02766
Ligands
H50, PO4
Pockets
2 · best druggability 0.34

Structure

x-ray diffraction · 2 distinct chains · 6% helix, 53% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ATransthyretinprotein1166% helix, 53% strandP02766
BTransthyretinprotein1156% helix, 53% strandP02766

Ligands and binding sites

  • H50 · 1-(3',4'-dichloro-2-fluorobiphenyl-4-yl) cyclopropanecarboxylic acid · ligand · 2 copies · chains A, B
  • PO4 · Phosphate ion · ion · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
1910.340.7417empty
2610.270.7318PO4

Interfaces

1 interface between chains.

  • A–B · 922 Ų buried · 20 hydrogen bonds · protein-protein

Compared structures

  • 6R6I · Crystal structure of transthyretin mutant A25T in complex with CHF5074, a flurbiprofen… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.